Comparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn’s disease: a systematic review and meta-analysis

BACKGROUND: Crohn’s disease is a relapsing disease that often requires operative management. Prevention of postoperative recurrence (POR) is critical to maintain remissions. Biologic agents have proven to be most successful in remission maintenance. We made a direct head-to-head comparison of the 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangwani, Manesh Kumar, Nawras, Mohamad, Aziz, Muhammad, Rani, Anooja, Priyanka, Fnu, Dahiya, Dushyant Singh, Ahmed, Zohaib, Sohail, Amir Humza, Karna, Rahul, Lee-Smith, Wade, Kamal, Faisal, Kobeissy, Abdallah, Alastal, Yaseen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152807/
https://www.ncbi.nlm.nih.gov/pubmed/37144019
http://dx.doi.org/10.20524/aog.2023.0786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152807/
https://www.ncbi.nlm.nih.gov/pubmed/37144019
http://dx.doi.org/10.20524/aog.2023.0786

Ejemplares similares